Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

SpectraFluidics' Chemical Detection Technology Sniffs Out Explosives with Canine-Like Precision

Published: Friday, November 23, 2012
Last Updated: Thursday, November 22, 2012
Bookmark and Share
Documents repeatable DNT detection capability of sensing technology developed at the University of California, Santa Barbara.

SpectraFluidics has demonstrated the repeatable performance capabilities of their novel sensor platform when used to detect DNT, an important chemical marker associated with TNT explosives.

SpectraFluidics Inc. Chief Scientist Dr. Brian Piorek said their research provides empirical test evidence of the efficacy of the breakthrough science behind the firm's Chemical Vapor Detection Cartridges.

Conducted in collaboration with scientists at UC Santa Barbara, tests showing the system's sensitivity and specificity were recently published in Analytical Chemistry, a journal of the American Chemical Society ('Free-Surface Microfluidics/Surface-Enhanced Raman Spectroscopy for Real-Time Trace Vapor Detection of Explosives', October 16, 2012.)

"This breakthrough capability for detecting vapors from explosives opens up tremendous commercial applications for the unattended and automated detection of trace levels of suspect chemicals, which can range from airport screening and port security to anti-bioterrorism and food supply safety," Philip Strong, CEO of SpectraFluidics commented.

Tests documented in the paper show the extraordinary sensitivity of this new generation of sensors that enable a user to identify the chemical signature of a substance within two minutes.

Dr. Piorek stated that it's this combination of sensitivity, chemical specificity, and speed that makes the technology so appealing to many homeland security, food and research applications.

"The researchers at SpectraFluidics and the UCSB Institute for Collaborative Biotechnologies have developed a fundamentally new approach for detecting chemicals at extremely low vapor phase concentrations," Dr. Piorek commented.

Dr. Piorek continued, "Employing an innovative combination of microfluidics and nanotechnology in our patented nanoscale vapor detection platform has enabled us to create a microsystem on a silicon chip that biomimics a dog's keen sense of smell."

Many existing chemical detection systems also use surface-enhanced Raman spectroscopy (SERS), a process that distributes or "scatters" photons of the material being tested to isolate individual molecules for identification purposes.

In contrast, SpectraFluidics' patented technology combines SERS with free-surface microfluidics, a process that draws liquid along a microscale channel which provides the effect of both concentrating molecules and greatly enhancing the Raman signal.

"Since the first proof of concept was completed several years ago, SpectraFluidics has been awarded key development contracts with multiple government agencies and is placing field trial products with leading manufacturers of security and analytical equipment," Strong added.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Blood Pressure Drug May Boost Effectiveness of Lung Cancer Treatment
Researchers at Imperial College London have suggested that the blood pressure drug may make a type of lung cancer treatment more effective.
Insight into Eye Diseases
Scientists recreate zebrafish cell regeneration from retinal stem cells in mice.
New Discovery May Benefit Farmers Worldwide
Scientists have shown how a crop-microbe 'team' protect against fungal infection.
Antibodies Paving the Way to HIV Vaccine
Researchers uncover factors responsible for the formation of broadly neutralizing HIV antibodies in humans.
Designing Drugs with a Whole New Toolbox
Researchers develop methods to design small, targeted proteins with shapes not found in nature.
Protein Studies Discover Molecular Secrets
Two protein studies have mapped proteins that reveal the secrets to recycling carbon and healing cells.
Tapping Evolution to Improve Biotech Products
Researchers show how 'ancestral sequence reconstruction' can be used to guide engineering of a blood clotting protein.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!